Latest Press Releases
View all
TimeHeadline
Just nowPodcastOne (Nasdaq: PODC) Anticipates Record FY 2026 Results of $61M+ Revenue and $6.3M+ Adjusted EBITDA*, Up +1,476% YOY
25m agoLinkhome Holdings Inc. Signs MOU to Acquire Mortgage One Group, Accelerating Nationwide Expansion of AI Real Estate & Fintech Platform
26m agoDeluxe and MRI Software Partner to Enhance Payment Capabilities for Property Management Companies
27m agoBox Launches Box Automate to Orchestrate Agentic Workflows
42m agoSCOR SE Combined Shareholders’ Meeting held on Tuesday 28 April 2026 - Approval of all resolutions by SCOR SE shareholders
Qualigen Therapeutics Inc logo

Qualigen Therapeutics Inc

About

Qualigen Therapeutics Inc (NASDAQ:QLGN) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 2 2026
Costamare Inc. Declares Quarterly Dividend on Its Preferred and Common Stock
Apr 2 2026
Freight Technologies Announces Strategic Update on Transition to AI-Powered, Software-First Logistics Technology Company
Apr 2 2026
Kraken Robotics Schedules Q4 and Year-End 2025 Financial Results Release and Webcast
Apr 2 2026
Hayasa Metals Announces 39m @ 0.50% Cu from Late Season Drill Hole at Urasar; Prospects Update
Apr 2 2026
Roundtable and RYVYL Announce Shareholders Approve Merger, with 99% of Votes Cast in Favor

Financials

Revenue
$4.98 M
Market Cap
$6.53 M
P/E Ratio
1.13
EPS
2.85

Community Chat

Ask AI

6ix6ix